plx4032 in metastatic colorectal cancer patients with mutant braf tumors scott kopetz 1, jayesh...
TRANSCRIPT
PLX4032 in Metastatic Colorectal Cancer Patients with Mutant BRAF Tumors
Scott Kopetz1, Jayesh Desai2, Emily Chan3, J Randolph Hecht4 , Peter J O’Dwyer5, Richard J Lee6, Keith B Nolop7, Suman Bhattacharya8, Leonard Saltz9
1 The University of Texas M.D. Anderson Cancer Center, Houston, TX; 2 Royal Melbourne Hospital, Parkville, Australia;
3 Vanderbilt-Ingram Cancer Center, Nashville, TN; 4 David Geffen School of Medicine at UCLA, Los Angeles, CA;
5 Abramson Cancer Center at University of Pennsylvania, Philadelphia, PA; 6 Roche, Nutley, NJ;
7 Plexxikon, Berkeley, CA; 8 Genentech, Inc., South San Francisco, CA;
9 Memorial Sloan-Kettering Cancer Center, New York, NY
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534
Kopetz, Desai, et al ASCO 2010 Abs# 3534